Literature DB >> 31054261

Exploring the Substrate Scope of the Bacterial Phosphocholine Transferase AnkX for Versatile Protein Functionalization.

Philipp Ochtrop1, Stefan Ernst2, Aymelt Itzen2, Christian Hedberg1.   

Abstract

Site-specific protein functionalization has become an indispensable tool in modern life sciences. Here, tag-based enzymatic protein functionalization techniques are among the most versatilely applicable approaches. However, many chemo-enzymatic functionalization strategies suffer from low substrate scopes of the enzymes utilized for functional labeling probes. We report on the wide substrate scope of the bacterial enzyme AnkX towards derivatized CDP-choline analogues and demonstrate that AnkX-catalyzed phosphocholination can be used for site-specific one- and two-step protein labeling with a broad array of different functionalities, displaying fast second-order transfer rates of 5×102 to 1.8×104  m-1  s-1 . Furthermore, we also present a strategy for the site-specific dual labeling of proteins of interest, based on the exploitation of AnkX and the delabeling function of the enzyme Lem3. Our results contribute to the wide field of protein functionalization, offering an attractive chemo-enzymatic tag-based modification strategy for in vitro labeling.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CDP-choline; dual labeling; phosphocholination; protein modifications; transferases

Mesh:

Substances:

Year:  2019        PMID: 31054261     DOI: 10.1002/cbic.201900200

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  2 in total

Review 1.  Bacterial virulence mediated by orthogonal post-translational modification.

Authors:  Kaitlin A Chambers; Rebecca A Scheck
Journal:  Nat Chem Biol       Date:  2020-09-17       Impact factor: 15.040

2.  Legionella effector AnkX displaces the switch II region for Rab1b phosphocholination.

Authors:  Stefan Ernst; Felix Ecker; Marietta S Kaspers; Philipp Ochtrop; Christian Hedberg; Michael Groll; Aymelt Itzen
Journal:  Sci Adv       Date:  2020-05-15       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.